1. Home
  2. UPC vs LIXT Comparison

UPC vs LIXT Comparison

Compare UPC & LIXT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • UPC
  • LIXT
  • Stock Information
  • Founded
  • UPC 1998
  • LIXT 2005
  • Country
  • UPC China
  • LIXT United States
  • Employees
  • UPC N/A
  • LIXT N/A
  • Industry
  • UPC Biotechnology: Pharmaceutical Preparations
  • LIXT Biotechnology: Pharmaceutical Preparations
  • Sector
  • UPC Health Care
  • LIXT Health Care
  • Exchange
  • UPC Nasdaq
  • LIXT Nasdaq
  • Market Cap
  • UPC 2.1M
  • LIXT 2.2M
  • IPO Year
  • UPC 2021
  • LIXT N/A
  • Fundamental
  • Price
  • UPC $3.38
  • LIXT $3.72
  • Analyst Decision
  • UPC
  • LIXT
  • Analyst Count
  • UPC 0
  • LIXT 0
  • Target Price
  • UPC N/A
  • LIXT N/A
  • AVG Volume (30 Days)
  • UPC 33.2K
  • LIXT 6.3M
  • Earning Date
  • UPC 07-25-2025
  • LIXT 08-07-2025
  • Dividend Yield
  • UPC N/A
  • LIXT N/A
  • EPS Growth
  • UPC N/A
  • LIXT N/A
  • EPS
  • UPC N/A
  • LIXT N/A
  • Revenue
  • UPC $19,293,003.00
  • LIXT N/A
  • Revenue This Year
  • UPC N/A
  • LIXT N/A
  • Revenue Next Year
  • UPC N/A
  • LIXT N/A
  • P/E Ratio
  • UPC N/A
  • LIXT N/A
  • Revenue Growth
  • UPC N/A
  • LIXT N/A
  • 52 Week Low
  • UPC $2.51
  • LIXT $0.64
  • 52 Week High
  • UPC $2,423.88
  • LIXT $4.45
  • Technical
  • Relative Strength Index (RSI)
  • UPC 42.03
  • LIXT 68.44
  • Support Level
  • UPC $3.53
  • LIXT $2.75
  • Resistance Level
  • UPC $3.96
  • LIXT $3.99
  • Average True Range (ATR)
  • UPC 0.23
  • LIXT 0.81
  • MACD
  • UPC 0.02
  • LIXT 0.16
  • Stochastic Oscillator
  • UPC 23.08
  • LIXT 81.65

About UPC Universe Pharmaceuticals Inc.

Universe Pharmaceuticals Inc is a pharmaceutical company specializing in the manufacturing, marketing, sales and distribution of traditional Chinese medicine derivatives products targeting the elderly with the goal of addressing their physical conditions in the ageing process and promoting their general well-being. The company also sells biomedical drugs, medical instruments, Traditional Chinese Medicine Pieces, and dietary supplements manufactured by third-party pharmaceutical companies. Its products are under two categories namely treatment and relief for common chronic health conditions in the elderly designed to achieve physical wellness and longevity (Chronic Condition Treatments), and cold and flu medications.

About LIXT Lixte Biotechnology Holdings Inc.

Lixte Biotechnology Holdings Inc is a biopharmaceutical company dedicated to improving patients' lives by developing a drug class called Protein Phosphatase 2A inhibitors. Its product pipeline is focused on inhibitors of protein phosphatase 2A, used in combination with cytotoxic agents and/or x-rays, immune checkpoint blockers, and other cancer therapies. The Company believes that inhibitors of protein phosphatases have therapeutic potential for a broad range of cancers. It focuses on the clinical development of a specific protein phosphatase inhibitor, referred to as LB-100, which has been shown to have clinical anti-cancer activity at doses that produce little or no toxicity.

Share on Social Networks: